🇺🇸 FDA
Patent

US 9072705

Oligo-benzamide compounds and their use in treating cancers

granted A61KA61K31/167A61K31/24

Quick answer

US patent 9072705 (Oligo-benzamide compounds and their use in treating cancers) held by The Board of Regents of the University of Texas System expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/167, A61K31/24, A61K31/365, A61K45/06